Jazz Pharmaceuticals PLC at JPMorgan NAPA Valley Forum (Virtual) Transcript
Great. Welcome back, everyone, as we continue the 2021 JPMorgan Virtual Napa Valley Biotech Forum. We're continuing the day sessions with Jazz, and I'm joined by a number of members of the management team, including the company's Chairman and CEO, Bruce Cozadd; Head of R&D and Chief Medical Officer, Robert Iannone; Chief Operating Officer, Dan Swisher; as well as Andrea Flynn, who heads up IR. (Operator Instructions)
You can use that as the session is going to send any questions through the portal, I can ask them to management. There's a little lag on that. So feel free to just send them as you think of them while we're going, and then I'll ask management.
So before we get into Q&A, Bruce, maybe you can just start with a couple of opening comments to kind of frame the conversation, and we can take it from there.
Yes. So Jess, great to be with you. And Dan, Rob and I are really excited
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |